Research Interests
Epidemiology Health Economics Health Policy Health Policy & Services Medical and Health Sciences Medical Devices Performance Evaluation Policy and Administration Public Health Public Health and Health Services Public Policy Surgical and Health Systems Innovation Indigenous and Disadvantaged Health Translational Health OutcomesProf Tracy Merlin
Dean, School of Public Health
School of Public Health
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Professor Merlin was the first Professor of Health Technology Assessment (HTA) in Australia, having worked in this sub-discipline of Public Health for over 25 years as an HTA methodologist and clinical epidemiologist. She has written over 200 systematic literature reviews, clinical practice guidelines, methods publications and health technology assessment reports.She is the Director and co-founder (2001) of Adelaide Health Technology Assessment (AHTA) at the University of Adelaide. In this role she leads a large and experienced team of researchers undertaking nationally significant applied research and evaluation activities on behalf of government and non-government agencies. This research directly informs health policy and clinical practice, including the funding of technologies on the Pharmaceutical Benefits Scheme and through Medicare. In 2023 Professor Merlin and her team were commissioned to provide expert advice and evidence on HTA to the Australian Government Health Technology Assessment Policy and Methods Review. Also, at the University of Adelaide, Professor Merlin is Head of the School of Public Health and Deputy Executive Dean of the Faculty of Health and Medical Sciences. She is Dean-elect of the School of Public Health at Adelaide University. The School of Public Health takes pride in offering high performance teaching and translational research across a number of public health areas including epidemiology and biostatistics, environmental and occupational health sciences, social and behavioural health sciences and healthy policy and health services. HTA is a policy science.Professor Merlin served as Chair of the Board of the International Network of Agencies for Health Technology Assessment (INAHTA) - a network of 50 not-for-profit and government HTA agencies across 30 countries - from 2020-2023 and is its longest serving Board member. She currently Chairs INAHTA's Nominating Committee and Co-Chairs the Scientific Programs Committee. She served as Chair of the English Editorial Board of the International HTA Glossary for 10 years and is now Co-Chair of the International Steering Committee. She is a founding member of Health Technology Assessment International (HTAi) and was instrumental in bringing the Society's international conference to Adelaide in 2023.Professor Merlin served as Chair of Academic Board at the University of Adelaide and was an ex-officio member of Council from 2022-2023.
Available Research Projects
For details on projects available please view the following booklet: School of Public Health Student Projects
Adelaide Health Technology Assessment (AHTA) 
Our Research
Adelaide Health Technology Assessment (AHTA) is an applied research group with a national and international reputation in Health Technology Assessment (HTA). AHTA has undertaken over $70 million in applied/contract research since its inception, primarily for the Australian Government Department of Health, to evaluate health services, medicines and other interventions to inform health policy and public funding decisions. This includes assessing the safety, effectiveness and cost-effectiveness of medical services that are being considered for Medicare funding; and the appraisal of pharmaceuticals to determine whether they warrant funding under the Pharmaceutical Benefits Scheme.
AHTA's aim is to improve public health and contribute to an efficient and equitable health system by informing health decisions with high quality evidence.
Our mission is to:
- evaluate the safety, effectiveness and value for money of health interventions
- inform evidence-based policy and practice in health using proven methods
- innovate, research and develop HTA and HTA methods
AHTA are proud members of:
Research and Teaching Interests
Prof. Merlin's research interests include:
- Developing methodologies for evaluating diagnostic tests to help policy-makers decide whether the tests should be publicly funded
- Developing methodologies for evaluating novel or disruptive technologies, such as mobile medical apps, breakthrough drugs and biosimilars, genetic technologies
- Developing methodologies for evaluating co-dependent technologies (eg. the combination of a test and a drug; two tests; a drug and a device), particularly when applied to cancer. For example, pharmacogenetics / personalised medicines.
- Assessing the impact of diagnostic tests or of co-dependent technologies on clinical or policy decision making
- Exploring the impact of HTA on policy-makers’ decisions
- Exploring how clinicians interpret evidence-based clinical practice guidelines
- Exploring the impact of evidence-based clinical practice guidelines on clinical practice
- Comparing the utility of different methods for grading recommendations in evidence-based clinical practice guidelines
- Comparing decision thresholds, between health systems, for determining the cost-effectiveness of technologies
- Mapping the impact of HTA on the Australian health system
- Mapping and categorising the different types of HTA and developing quality assurance criteria for each type of HTA product.
- Exploring the impact of real world evidence on reimbursement decisions for health technologies
- Assessing health system approaches to reducing the impact of antimicrobial resistance
Prof. Merlin's teaching interests include:
- Health technology assessment
- Clinical epidemiology
- Systematic reviews and meta-analysis
- Horizon scanning for new and emerging technologies
- Evaluating medical services, devices, programs or pharmaceuticals to help policy-makers decide whether they should be publicly funded
- Evaluating medical services or health interventions to inform health professionals and clinicians make the best choice when diagnosing or treating a patient
- Evaluating currently funded medical services devices, programs or pharmaceuticals to help policy-makers decide whether they should be ‘disinvested’ or stripped of public funding.
Professional Activities
Prof. Merlin has been an active board member, Chair, and committee member of a significant number of committees, boards and working groups falling under the umbrella of various international, national and state health technology assessment organisations.
She Chaired the International Network of Agencies for Health Technology Assessment (INAHTA) from 2020-2023 and was on the Board for 8 years. She Chaired the HTA Glossary English Editorial Board for 10 years, on behalf of Health Technology Assessment international (HTAi) and INAHTA, and she currently co-Chairs the International Steering Committee.
| Date | Position | Institution name |
|---|---|---|
| 2024 - ongoing | Head, School of Public Health | University of Adelaide |
| 2024 - ongoing | Deputy Executive Dean, Faculty of Health and Medical Sciences | University of Adelaide |
| 2022 - 2023 | Chair, Academic Board and ex-officio member of Council | University of Adelaide |
| 2019 - 2023 | Interim Head, School of Public Health | University of Adelaide |
| 2017 - ongoing | Professor of Health Technology Assessment | University of Adelaide |
| 2017 - ongoing | Director | Adelaide Health Technology Assessment (AHTA), School of Public Health, University of Adelaide |
| 2016 - 2018 | Academic Lead, Health Economics & Policy Academic Unit | School of Public Health, University of Adelaide |
| 2015 - 2018 | Acting Head, School of Public Health (Intermittent) | University of Adelaide |
| 2015 - 2016 | Managing Director, Data Management and Analysis Centre | School of Public Health, University of Adelaide |
| 2013 - 2016 | Associate Professor and Senior Research Fellow (Level D) | School of Public Health, University of Adelaide |
| 2010 - 2016 | Managing Director | Adelaide Health Technology Assessment (AHTA), School of Public Health, University of Adelaide |
| 2010 - 2012 | Senior Research Fellow (Level C) | Discipline of Public Health, School of Population Health, University of Adelaide |
| 2001 - 2010 | Manager, Adelaide Health Technology Assessment (and the National Horizon Scanning Unit) | Discipline of Public Health, School of Population Health and Clinical Practice, University of Adelaide |
| 1998 - 2001 | Senior Research Officer | Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S), Royal Australasian College of Surgeons |
| 1990 - 1997 | Research Officer | Department of Medicine, The Queen Elizabeth Hospital, University of Adelaide |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2021 | Invitation | Invited to join Vice Chancellor’s Key Leaders’ Leadership Development Program | University of Adelaide | Australia | - |
| 2019 | Nomination | Short-listed for Vice Chancellor’s Inaugural Award for Excellence in Research | University of Adelaide | Australia | - |
| 2019 | Invitation | Invited to join Faculty of Health & Medical Sciences Advancing Leadership Program | University of Adelaide | Australia | - |
| 2018 | Award | 2018 David Hailey Impact Award | International Network of Agencies for Health Technology Assessment (INAHTA) | Canada | - |
| 2016 | Award | Best poster presentation | HTAi | - | - |
| 2016 | Award | Best HDR Supervisor, School of Public Health | University of Adelaide | Australia | - |
| 2016 | Invitation | Accepted into the Adelaide Women Leaders Program | University of Adelaide | Australia | - |
| 2015 | Honour | School of Public Health Academic Leadership Honour Roll | University of Adelaide | Australia | - |
| 2008 | Award | Best student oral presentation | HTAi | Canada | $1,000 |
| 2007 | Award | ARI Inaugural Impact Award for Growth in Contract Research | Adelaide Research and Innovation | Australia | $10,000 |
| 2006 | Award | Poster Prize | HTAi | Australia | $1,000 |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2014 - 2015 | University of Adelaide | Australia | Graduate Certificate in Online Learning (Higher Education) |
| 2012 - 2013 | FPMS International Management Consultants and Accredited Training Providers | Australia | Advanced Diploma in Project Management |
| 2007 - 2015 | University of Adelaide | Australia | PhD (Medicine) |
| 1998 - 2001 | University of Adelaide | Australia | Master of Public Health |
| 1989 - 1989 | University of Adelaide | Australia | Honours, Bachelor of Arts |
| 1986 - 1989 | University of Adelaide | Australia | Bachelor of Arts |
| Year | Citation |
|---|---|
| 2023 | Carter, D., Kessels, S., & Merlin, T. (2023). Toward a framework for assessing ethical considerations relating to genetic tests. In 2023 Health Technology Assessment International (HTAi) Annual Meeting. Adelaide. |
| 2022 | Laka, M., Carter, D., & Merlin, T. (2022). Gaps in the Evaluation of Clinical Decision Support Software (CDSS): Interviews with Australian Policymakers. In Health Technology Assessment International (HTAi) Annual Meeting. Utrecht, The Netherlands. DOI |
| 2021 | Laka, M., Milazzo, A., & Merlin, T. (2021). Challenges and opportunities to appropriate antibiotic prescribing: a survey of clinicians' perceptions in Australia. In INTERNATIONAL JOURNAL OF EPIDEMIOLOGY Vol. 50 (pp. 2 pages). OXFORD UNIV PRESS. |
| 2021 | Laka, M., Milazzo, A., Carter, D., & Merlin, T. (2021). From Pilot Studies To System-Wide Innovation: Challenges And Opportunities For Clinical Decision Support Systems (CDSS) Implementation In Australia. In International Journal of Technology Assessment in Health Care , Volume 37 , Special Issue S1: Innovation through HTA , December 2021 Vol. 37 (pp. 5-6). Manchester: Cambridge University Press (CUP). DOI |
| 2019 | Laka, M., Milazzo, A., & Merlin, T. (2019). Sustainable Implementation of Electronic Decision Support Tools for the Evidence-based Management of Antibiotics. In Proceedings of the 9th International Conference on Digital Public Health (pp. 7-8). online: ACM. DOI Scopus1 WoS1 |
| 2018 | Carter, D. A., Vogan, A., & Merlin, T. (2018). The need for ethics committees and evaluation agencies in coverage with evidence development: the case of crizotinib in Australia. In Australasian Association of Bioethics and Health Law Conference. Townsville. |
| 2017 | Carter, D. A., Merlin, T., & Hunter, D. (2017). Coercing or inducing patients to participate in evidence generation. In Australasian Association of Philosophy Conference. Adelaide. |
| 2015 | Lopes McInnes, E., Street, J., Carter, D., & Merlin, T. (2015). Stakeholder views on Australian public- and patient-involvement in HTA. In Online programme. Oslo, Norway. |
| 2013 | Lopes do Carmo, E., Street, J. M., Carter, D. A., & Merlin, T. L. (2013). Excluding patient and citizen voices from health-care funding decision-making: what is the public health impact?. In Public Health Association of Australia (PHAA) 42nd Annual Conference. Melbourne, Australia. |
| 2005 | Merlin, T. L., Hodgkinson, B., Moss, J., & Hiller, J. E. (2005). Economic analysis within a health technology assessment: practical issues. In Italian Journal of Public Health (Supplement 1) Vol. 2 (pp. 262). Rome, Italy. |
| 2005 | Mundy, L., Merlin, T. L., Parrella, A., & Hiller, J. E. (2005). The Australian horizon scanning network. In Italian Journal of Public Health (Supplement 1) Vol. 2 (pp. 163). Rome, Italy. |
| 2005 | Merlin, T. L., Weston, A., & Tooher, R. (2005). Revising a national standard: redevelopment of the Australian NHMRC evidence hierarchy. In Italian Journal of Public Health (Supplement 1) Vol. 2 (pp. 156). Rome, Italy. |
| Year | Citation |
|---|---|
| 2024 | Schubert, C., Jackson, M., Barnett, C., Scott, H., Goodall, S., & Merlin, T. (2024). Exome or genome sequencing for perinatal autopsy: A 'before and after' change-in-management study. Poster session presented at the meeting of Human Genetics Society of Australasia (HGSA) Annual Meeting. Gold Coast, Queensland, Australia. |
| 2023 | Gao, Y., Laka, M., & Merlin, T. (2023). Is The Quality Of Evidence in HTA Deteriorating Over Time?: A Case Study on Cancer Drugs In Australia. Poster session presented at the meeting of Health Technology Assessment International. |
| 2022 | Hillock, N., Chen, G., Turnidge, J., Louise, J., Merlin, T., & Karnon, J. (2022). IS IT WORTH THE MONEY? HEALTHCARE PRACTITIONERS' WILLINGNESS TO PAY FOR NARROW SPECTRUM AND OTHER ATTRIBUTES OF ANTIMICROBIALS. Poster session presented at the meeting of JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. ELSEVIER SCI LTD. |
| 2022 | Hillock, N., Chen, G., Turnidge, J., Louise, J., Merlin, T., & Karnon, J. (2022). NAUSP METHODOLOGY UPDATES AND APPLICATION OF THE PRIORITY ANTIBACTERIAL LIST IN AUSTRALIAN ACUTE-CARE HOSPITALS, 2019-21. Poster session presented at the meeting of JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. ELSEVIER SCI LTD. |
| 2021 | Lopes McInnes, E., Stafinski, T., Carter, D., Merlin, T., & Street, J. (2021). Stakeholders' perspectives on public involvement in health technology assessment in Canada. Poster session presented at the meeting of Health Technology Assessment International (HTAi) 2021 Annual Meeting. UK: Health Technology Assessment International. |
| 2020 | Laka, M., Milazzo, A., & Merlin, T. (2020). Why provision of clinical decision support (CDS) is not enough? Factors influencing the CDS adoption. Poster session presented at the meeting of EUROPEAN JOURNAL OF PUBLIC HEALTH. OXFORD UNIV PRESS. DOI WoS2 |
| 2019 | Newton, S., Kessels, S., Vogan, A., & Merlin, T. (2019). Shift From Regional To Federal Funding: Methodological Considerations. Poster session presented at the meeting of XVI Annual Meeting, Health Technology Assessment international (HTAi). Cologne, Germany. |
| 2019 | Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2019). Policy incentives for a sustainable antibiotic market: the perspective of Australian stakeholders - a qualitative study (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019. |
| 2019 | Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Special Access Scheme Category C and antimicrobial drugs - a policy solution or a temporary fix? (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019. |
| 2019 | Moshi, M., Parsons, J., Tooher, R., & Merlin, T. (2019). mHealth app evaluation framework for reimbursement decision-making. Poster session presented at the meeting of Health Technology Assessment International (HTAi) Annual Meeting. Cologne, Germany. |
| 2019 | Moshi, M., Parsons, J., Tooher, R., & Merlin, T. (2019). Assessment of mHealth apps: is current regulation policy adequate?.. Poster session presented at the meeting of Health Technology Assessment International (HTAi) Annual Meeting. Cologne, Germany. |
| 2019 | Moshi, M. R., Tooher, R., & Merlin, T. (2019). mHealth app evaluation framework for decision-making purposes. Poster session presented at the meeting of 13th Annual Florey Postgraduate Research Conference. |
| 2018 | Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2018 Symposium (2018). Poster session presented at the meeting of Diagnostic and Prognostic Research. Springer Science and Business Media LLC. DOI |
| 2018 | Milverton, J., Newton, S., Vogan, A., Schubert, C., & Merlin, T. (2018). Methodology to assess a predictive test for breast cancer recurrence. Poster session presented at the meeting of Abtracts of the Annual Meeting HTAi 2018. Vancouver, Canada: Health Technology Assessment international (HTAi). |
| 2018 | Moshi, M. R., Parsons, J., Tooher, R., & Merlin, T. (2018). Assessment of mHealth apps in Australia: is current regulation adequate? [Poster]. Poster session presented at the meeting of Florey Postgraduate Research Conference. Adelaide, South Australia. |
| 2018 | Moshi, M. R., Tooher, R., & Merlin, T. (2018). Suitable frameworks for mHealth app evaluation n Australian healthcare reimbursement [Rapid Fire Presentation and Poster]. Poster session presented at the meeting of The Annual Scientific Meeting of the Australasian Epidemiological Association. Freemantle, Western Australia. |
| 2018 | Moshi, M. R., Parsons, J. E., Tooher, R. L., & Merlin, T. L. (2018). Assessment of mHealth apps in Australia: is current regulation policy adequate? [Presentation]. Poster session presented at the meeting of South Australian Population Health Conference. Adelaide, South Australia. |
| 2018 | Freeman-Robinson, M. K., Merlin, T. L., Mihalopoulos, C., & Roughead, E. (2018). Securing access to medicines using discounts in Australia. Poster session presented at the meeting of the 15th Annual Health Technology Assessment international (HTAi) Conference. Vancouver, Canada. |
| 2018 | Freeman-Robinson, M. K., Mihalopoulos, C., Merlin, T. L., & Roughead, E. (2018). Decision criteria that influence managed entry agreements. Poster session presented at the meeting of the 15th Annual Health Technology Assessment international (HTAi) Conference. Vancouver, Canada. |
| 2018 | Strachan, L., Lewis, S., & Merlin, T. L. (2018). The Value-based Health Care Movement – What Role Does HTA Play?. Poster session presented at the meeting of the 15th Annual Health Technology Assessment international (HTAi) Conference. Vancouver, Canada. |
| 2018 | Merlin, T. L., Belorgey, C., Mejia, A., McCabe, C., & Kim, S. (2018). Promise or compromise? The value of RWE in HTA: INAHTA members’ experiences. Poster session presented at the meeting of the 15th Annual Health Technology Assessment international (HTAi) Conference. Vancouver, Canada. |
| 2018 | Kessels, S., Newton, S., Carter, D., & Merlin, T. (2018). The Effectiveness And Ethics Of Prenatal Testing For Cystic Fibrosis. Poster session presented at the meeting of HTAi Annual Meeting 2018. Vancouver. |
| 2017 | Vogan, A., Schubert, C., & Merlin, T. (2017). The Impact Of Treatment Timing On The Cost-Effectiveness Of Tests. Poster session presented at the meeting of the 14th Annual Health Technology Assessment international (HTAi) Conference. Rome, Italy. |
| 2017 | Merlin, T. L., Hiller, J. E., & Ryan, P. (2017). Does HTA methodology affect the decision to fund medical tests?. Poster session presented at the meeting of the 14th Annual Health Technology Assessment international (HTAi) Conference. Rome, Italy. |
| 2017 | Hausner, E., Merlin, T. L., O'Rourke, B., Chalon, P., Mejia, A., & Waffenschmidt, S. (2017). Rescuing the HTA database – future options and challenges. Poster session presented at the meeting of the 14th Annual Health Technology Assessment international (HTAi) Conference. Rome, Italy. |
| 2017 | Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2017). Investigating the utilisation of unregistered antimicrobial drugs in Australia. Poster session presented at the meeting of Florey Postgraduate Research Conference. Adelaide. |
| 2016 | Merlin, T. L., Mujoomdar, M., Ahn, J., Dedeu, I., & Baraldes, T. (2016). Getting a grip on new technologies: INAHTA member agency experiences with m-health, apps, telehealth, and other point-of-care technologies. Poster session presented at the meeting of the 13th Annual Health Technology Assessment international (HTAi) Conference. Tokyo, Japan. |
| 2016 | Merlin, T. L., Panteli, D., Espin, J., Lepanto, L., & Ramsay, C. (2016). HTA in academic curricula: demand, experience, ways forward and potential for collaboration. Poster session presented at the meeting of the 13th Annual Health Technology Assessment international (HTAi) Conference. |
| 2016 | Moshi, M. R., Tooher, R., & Merlin, T. (2016). Determining the feasibility of reimbursing mobile health apps in Australia [Presentation]. Poster session presented at the meeting of Presentation. Alice Springs, Northern Territory. |
| 2016 | Merlin, T., & Moshi, M. R. (2016). Getting a grip on new technologies: AHTA’s journey into m-health and mobile medical applications (MMAs) [Presentation]. Poster session presented at the meeting of the 13th Annual Health Technology Assessment international (HTAi) Conference. Tokyo, Japan. |
| 2016 | Vogan, A., Schubert, C., Newton, S., & Merlin, T. (2016). What are we missing by limiting the outcome of cost effectiveness analyses of diagnostic tests to cost per correct result?. Poster session presented at the meeting of the 13th Annual Health Technology Assessment international (HTAi) Conference. Tokyo, Japan. |
| 2015 | Vogan, A., Mitchell, A., Tamblyn, D., & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway. |
| 2015 | Morona, J. K., Newton, S., & Merlin, T. L. (2015). Meta-analysis of Two Tests via a Common Reference Standard for Detection of Tuberculosis Infections. Poster session presented at the meeting of 12th Annual Health Technology Assessment International (HTAi) Conference. Oslo, Norway. |
| 2015 | Kessels, S., Morona, J. K., Newton, S. S., & Merlin, T. L. (2015). The impact of an imperfect reference standard. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway. |
| 2015 | Pridham, L., Liufu, Z., Newton, S., & Merlin, T. (2015). Abstract: 294 - International comparison of subsidisation of drugs for rare diseases and the definitions for a rare/ultra-rare disease. Poster session presented at the meeting of HTAi 2014 - 12th Annual Meeting. Oslo, Norway. |
| 2015 | Merlin, T. L., Mujoomdar, M., Kisser, A., & Wurcel, V. (2015). Living in testing times: translating evidence on medical tests and companion diagnostics into reimbursement decisions. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway. |
| 2015 | Merlin, T. L. (2015). HTA for companion diagnostics: different models and best practices to make it possible. Poster session presented at the meeting of European Diagnostics Manufacturers Association. Brussels, Belgium. |
| 2014 | Merlin, T. L. (2014). Standardising health technology assessment to enhance transferability across jurisdictions and nations: the first step towards a solution. Poster session presented at the meeting of 3rd Health Technology Assessment Conference. Sydney, NSW. |
| 2014 | Merlin, T. L. (2014). Two by two – a methodological perspective on the use of evidence to support the value of a health care technology. Poster session presented at the meeting of New Zealand Health Care Congress. Auckland, New Zealand. |
| 2014 | Merlin, T. L., & Schubert, C. (2014). Evaluating Medical Tests for Coverage Decisions Using the Linked Evidence Approach. Poster session presented at the meeting of the 11th Annual Health Technology Assessment international (HTAi) Conference. Washington, DC, USA. |
| 2014 | Kessels, S., Schubert, C., Newton, S. S., & Merlin, T. (2014). Assessment of catheter-free (wireless) ambulatory oesophageal pH monitoring for Gastro-esophageal Reflex Disease (GORD). Poster session presented at the meeting of Health Technology Assessment International. Washington, DC. |
| 2014 | Milverton, J., Ellery, B., Newton, S. S., Kessels, S., Gum, D., & Merlin, T. L. (2014). CT colonography for those at high risk or symptomatic for colorectal cancer. Poster session presented at the meeting of the 11th Annual Health Technology Assessment international (HTAi) Conference. Washington, D.C., USA. |
| 2014 | Vogan, A., Schubert, C., Parsons, J., Morona, J., & Merlin, T. (2014). The impact of an imperfect diagnostic reference standard on the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes. Poster session presented at the meeting of the 11th Annual Health Technology Assessment international (HTAi) Conference. Washington D.C., USA. |
| 2014 | Vogan, A., Schubert, C., Parsons, J., Morona, J., & Merlin, T. (2014). Assessing the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes and the impact of an imperfect diagnostic reference standard. Poster session presented at the meeting of the 36th Annual North American Meeting Society for Medical Decision Making (SMDM). Miami, USA. |
| 2013 | Morona, J. K., Buckley, E. S., Reddin, E. A., & Merlin, T. L. (2013). The use of growth factors to promote healing of diabetic foot ulcers: A Systematic Review.. Poster session presented at the meeting of 2013 Australasian Cochrane Symposium. Melbourne, VIC. |
| 2013 | • Haji Ali Afzali, H., Karnon, J., Merlin, T., & Hajiali Afzali, H. (2013). Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models.. Poster session presented at the meeting of the 10th Annual Health Technology Assessment international (HTAi) Conference. Seoul, South Korea. |
| 2013 | Moshi, M. R., Tamblyn, D., & Merlin, T. (2013). Rise of Co-dependent Technologies: Surveying Stakeholders’ about their opinion on the co-dependent technology framework and decision-making process [Poster]. Poster session presented at the meeting of SA State Population Health Conference. Adelaide, South Australia. |
| 2013 | Newton, S., Wang, S., Schubert, C., & Merlin, T. (2013). One small step for an individual, one giant leap for their family: considerations required for assessing the cost effectiveness of genetic tests. Poster session presented at the meeting of the 10th Annual Health Technology Assessment international (HTAi) Conference. Seoul, South Korea. |
| 2013 | Newton, S. S., Fitzgerald, P., & Merlin, T. (2013). Mutation testing of the RET gene for MEN2. Poster session presented at the meeting of the 10th Annual Health Technology Assessment international (HTAi) Conference. Seoul, South Korea. |
| 2013 | Morona, J., Newton, S. S., Ellery, B., & Merlin, T. (2013). Genetic testing for VHL disease: limited benefit to the individual, but reduced surveillance for family members. Poster session presented at the meeting of the 10th Annual Health Technology Assessment international (HTAi) Conference. Seoul, South Korea. |
| 2013 | Merlin, T. L., Ellery, B., Juneja, V., & Tamblyn, D. (2013). What’s in a name? - Mapping the different HTA products of INAHTA members. Poster session presented at the meeting of the 10th Annual Meeting Health Technology Assessment international (HTAi). Seoul, South Korea. |
| 2013 | Street, J., Marciano, N., Merlin, T. L., & Bessen, T. (2013). How good is the guidance for cutaneous melanoma follow- up? A systematic review of clinical practice guidelines. Poster session presented at the meeting of FCIC Survivorship Conference. Adelaide, SA. |
| 2013 | Merlin, T. L. (2013). Coverage with evidence development: when is it appropriate?. Poster session presented at the meeting of ARCS Health Economics Conference. National Convention Centre, Canberra, ACT. |
| 2012 | Merlin, T. L. (2012). Examining the challenges to health technology assessment from personalised medicine: the need for innovative approaches. Poster session presented at the meeting of the 1st Health Technology Assessment Conference. Sydney, NSW. |
| 2012 | Merlin, T. L. (2012). Impact of Health Technology Assessment – AHTA’s perspective. Poster session presented at the meeting of International Network of Agencies for Health Technology Assessment Annual Meeting. Bilbao, Spain. |
| 2012 | Merlin, T. L., Farah, C., Schubert, C., Mitchell, A., Hiller, J. E., & Ryan, P. (2012). How to assess personalised medicines for reimbursement decisions? Developing a framework for Australia. Poster session presented at the meeting of the 9th Annual Health Technology Assessment international (HTAi) Conference. Bilbao, Spain. |
| 2012 | Merlin, T. L., & Street, J. (2012). Keeping an eye on the problem: developing a disinvestment methodology to review Australian medical services – ‘ophthalmology’ as a test case. Poster session presented at the meeting of the 9th Annual Health Technology Assessment international (HTAi) Conference. Bilbao, Spain. |
| 2011 | Hennessy, S., Street, J., Scrimgeour, S., & Merlin, T. L. (2011). A rapid review of patient perspectives on cataract surgery collected using peer-reviewed literature and personal blogs: a comparison with patient interviews. Poster session presented at the meeting of HSRAANZ Health services and policy research conference. Adelaide, SA. |
| 2011 | Street, J., Hennessy, S., Scrimgeour, S., & Merlin, T. L. (2011). A rapid review of patient perspectives on ophthalmology services using peer reviewed literature and personal blogs. Poster session presented at the meeting of the 8th Annual Health Technology Assessment international (HTAi) Conference. Rio de Janeiro, Brazil. |
| 2011 | Merlin, T. L. (2011). Challenges for independent evaluation: MSAC assessments – past, present and future. Poster session presented at the meeting of ARCS Scientific Congress. National Convention Centre, Canberra, ACT. |
| 2011 | Merlin, T. L. (2011). The FORM grading method: advantages and challenges. Poster session presented at the meeting of National Health and Medical Research Council Guideline Development Symposium. Melbourne, VIC. |
| 2011 | Merlin, T. L. (2011). Feasibility of the linked evidence approach when assessing diagnostic tests for public funding. Poster session presented at the meeting of Screening and Test Evaluation Program (STEP) Seminar. University of Sydney, Sydney, NSW. |
| 2010 | Merlin, T. L. (2010). Rationale for proposed description of evidence needs. Poster session presented at the meeting of ARCS Scientific Congress. National Convention Centre, Canberra, ACT. |
| 2010 | Merlin, T. L. (2010). Developing a framework for co-dependent technologies for reimbursement. Poster session presented at the meeting of Test Evaluation Symposium. NHMRC Clinical Trials Centre and Screening and Test Evaluation Program (STEP). University of Sydney, Sydney, NSW. |
| 2010 | Merlin, T. L. (2010). Personalised medicine initiatives. Poster session presented at the meeting of Evidence-based Pathology Seminar, The Royal College of Pathologists of Australasia. Coogee Beach, Sydney, NSW. |
| 2010 | Merlin, T. L., & Lehman, S. (2010). The benefits and flaws of the Linked Evidence Approach (LEA) to assess diagnostic and screening tests. Poster session presented at the meeting of the 7th Annual Health Technology Assessment international (HTAi) Conference. Dublin, Ireland. |
| 2010 | Merlin, T. L., & Liufu, Z. (2010). Unattended sleep studies in the diagnosis of obstructive sleep apnoea. Poster session presented at the meeting of the 7th Annual Health Technology Assessment international (HTAi) Conference. Dublin, Ireland. |
| 2010 | Buckley, E., Wang, S., Merlin, T. L., & Hiller, J. E. (2010). Use of disease prevalence when estimating the positive predictive value of a test can mislead: the spectrum effect. Poster session presented at the meeting of the 7th Annual Health Technology Assessment international (HTAi) Conference. Dublin, Ireland. |
| 2010 | Buckley, E., Merlin, T. L., Mundy, L., & Hiller, J. E. (2010). Molecular testing for myeloproliferative disease: The conundrum of an imperfect reference standard. Poster session presented at the meeting of the 7th Annual Health Technology Assessment international (HTAi) Conference. Dublin, Ireland. |
| 2009 | Ju, H., Newton, S., Merlin, T. L., & Hiller, J. E. (2009). Quality assessment of clinical practice guidelines (CPGs): Is ADAPTE adaptable?. Poster session presented at the meeting of the 6th Annual Health Technology Assessment international (HTAi) Conference. Singapore. |
| 2009 | Wang, S., Gum, D., Merlin, T. L., & Hiller, J. E. (2009). Predictors of vaccination uptake and course completion: A systematic review. Poster session presented at the meeting of the 6th Annual Health Technology Assessment international (HTAi) Conference. Singapore. |
| 2009 | Newton, S. S., Street, J., Merlin, T., & Hiller, J. (2009). Is MRI effective for staging newly diagnosed rectal carcinoma? That depends on whether it changes management.. Poster session presented at the meeting of the 6th Annual Health Technology Assessment international (HTAi) Conference. Singapore. |
| 2008 | Wang, S., Merlin, T. L., Kreisz, F., Craft, P., & Hiller, J. E. (2008). Cost-effectiveness of digital mammography compared with film-screen mammography in Australia. Poster session presented at the meeting of the Population Health Congress. Brisbane, QLD. |
| 2008 | Kreisz, F. P., Merlin, T. L., Hiller, J. E., & Gericke, C. (2008). The cost-utility of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease. Poster session presented at the meeting of the 5th Annual Health Technology Assessment international (HTAi) Conference. Montreal, Canada. |
| 2008 | Merlin, T. L., Moss, J., & Hiller, J. E. (2008). Location, location, location – the impact of health care setting of technology use on both HTA results and funding policy. Poster session presented at the meeting of the 5th Annual Health Technology Assessment international (HTAi) Conference. Montreal, Canada. |
| 2008 | Merlin, T. L., Newton, S., Wang, S., & Hiller, J. E. (2008). Technology assessment in the context of workforce shortages and changing supply: digital mammography. Poster session presented at the meeting of the 5th Annual Health Technology Assessment international (HTAi) Conference. Montreal, Canada. |
| 2008 | Kreisz, F. P., Merlin, T. L., Hiller, J. E., & Gericke, C. (2008). The cost-utility of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease. Poster session presented at the meeting of the 7th European Conference on Health Economics. Rome, Italy. |
| 2007 | Ivan, M., Merlin, T. L., Hiller, J. E., Newton, S., Sullivan, T., Buckley, E., & Hedayati, H. (2007). Multi-slice computed tomography or conventional coronary angiography – how a systematic review of safety and effectiveness can inform decision-making. Poster session presented at the meeting of the State Population Health conference. Adelaide, SA. |
| 2007 | Hiller, J. E., Moyes, L., Mundy, L., & Merlin, T. L. (2007). Horizon scanning for public health interventions. Poster session presented at the meeting of the 4th Annual Health Technology Assessment international (HTAi) Conference. Barcelona, Spain. |
| 2007 | Branham, D., Merlin, T. L., & Woollacott, T. (2007). Evaluating overweight/obesity health promotion activities on multiple criteria (of effectiveness, efficiency and equity). Poster session presented at the meeting of the Australian Health Promotion Association’s 17th National Conference. Adelaide, SA. |
| 2006 | Merlin, T. L., Brooks, A., Lord, S., & Hiller, J. E. (2006). How to assess the effectiveness of a triage test in the context of direct versus linked evidence?. Poster session presented at the meeting of the 3rd Annual Health Technology Assessment international (HTAi) Conference. Adelaide, SA. |
| 2006 | Sullivan, T., Merlin, T. L., Mundy, L., & Hiller, J. E. (2006). Horizon scanning activity as a marker for changing patterns in medical research. Poster session presented at the meeting of the 3rd Annual Health Technology Assessment international (HTAi) Conference. Adelaide, SA. |
| 2006 | McCaffrey, N., Merlin, T. L., & Hiller, J. E. (2006). Lack of clinical rationale provided for non-inferiority margins. Poster session presented at the meeting of the 3rd Annual Health Technology Assessment international (HTAi) Conference. Adelaide, SA. |
| 2006 | Mundy, L., Merlin, T. L., Hiller, J. E., & Sullivan, T. (2006). Determining the fate of a health technology: why some technologies don’t get off first base. Poster session presented at the meeting of the 3rd Annual Health Technology Assessment international (HTAi) Conference. Adelaide, SA. |
| 2006 | Newton, S. S., Merlin, T., Forbes, D., Phelps, A., Creamer, M., & Hiller, J. E. (2006). Challenges in updating clinical practice evidence-based guidelines. Poster session presented at the meeting of the 3rd Annual Health Technology Assessment international (HTAi) Conference. Adelaide, SA. |
| 2006 | Newton, S. S., Merlin, T., Hedayati, H., Thomson, K., & Hiller, J. E. (2006). Kyphoplasty for treating vertebral compression fractures with kyphosis. Poster session presented at the meeting of the 3rd Annual Health Technology Assessment International (HTAi) Conference. Adelaide, SA. |
| 2006 | Merlin, T., Newton, S. S., Thomson, K., & Hiller, J. E. (2006). Brittle bones and painful backs: a systematic review of the safety and effectiveness of vertebroplasty. Poster session presented at the meeting of the 3rd Annual Health Technology Assessment international (HTAi) Conference. Adelaide, SA. |
| 2005 | Merlin, T. L., Middleton, P., Salisbury, J., & Weston, A. (2005). Ways to ensure evidence-based clinical practice guidelines are of high quality. Poster session presented at the meeting of the 8th Cochrane Colloquium. Melbourne, VIC. |
| 2005 | Merlin, T. L., Weston, A., & Tooher, R. (2005). Re-assessing and revising “levels of evidence” in the critical appraisal process. Poster session presented at the meeting of the 8th Cochrane Colloquium. Melbourne, VIC. |
| 2004 | Hodgkinson, B., Moss, J., Merlin, T. L., & Hiller, J. E. (2004). Economic analysis within a health technology assessment: practical issues. Poster session presented at the meeting of Regional Conference on Cost Effective Healthcare. Singapore. |
| 2004 | Merlin, T. L., & Hiller, J. E. (2004). Are institutionalised approaches to pain assessment and management effective? A systematic review. Poster session presented at the meeting of the 1st Annual Health Technology Assessment international (HTAi) Conference. Krakow, Poland. |
| 2004 | Merlin, T. L., Mundy, L., & Hiller, J. E. (2004). Caught between a rock and a hard place: indirect comparisons and the trade-off between information and methodological rigour. Poster session presented at the meeting of the 1st Annual Health Technology Assessment international (HTAi) Conference. Krakow, Poland. |
| 2004 | Merlin, T. L., Hiller, J. E., Babidge, W., McConnell, A., & Kearney, B. (2004). The development of the Australia and New Zealand Horizon Scanning Network and its impact on policy. Poster session presented at the meeting of the 1st Annual Health Technology Assessment international (HTAi) Conference. Krakow, Poland. |
| 2003 | Merlin, T. L. (2003). Indirect comparisons, Workshop 2 - Methods: Therapy. Poster session presented at the meeting of MSAC Evaluator’s Meeting. Melbourne, VIC. |
| 2003 | Merlin, T. L. (2003). Laparoscopic live donor nephrectomy. Poster session presented at the meeting of British Journal of Surgery. Melbourne, VIC: Oxford University Press (OUP). DOI Scopus5 Europe PMC6 |
| 2003 | Merlin, T. L., & Hiller, J. R. (2003). Are institutionalised approaches to pain assessment and management effective? A systematic review. Poster session presented at the meeting of Health Services Research Association of Australia and New Zealand Conference. Melbourne, VIC. |
| 2003 | Hodgkinson, B., Moss, J., Merlin, T. L., & Hiller, J. E. (2003). When the comparator is 'usual care': an example from osteoarthritis of the knee. Poster session presented at the meeting of the International Society of Technology Assessment in Health Care, 19th Annual Meeting. Canmore, Canada. |
| 2003 | Merlin, T. L., Mundy, L., Dekker, G. A., & Hiller, J. E. (2003). Antenatal screening for heritable thrombophilia: Is public funding merited?. Poster session presented at the meeting of the International Society of Technology Assessment in Health Care, 19th Annual Meeting. Canmore, Canada. |
| 2003 | Merlin, T. L., Mundy, L., Dekker, G., & Hiller, J. E. (2003). Antenatal screening for heritable thrombophilia: what is the evidence?. Poster session presented at the meeting of the Perinatal Society of Australia and New Zealand Congress. Hobart, TAS. |
| 2002 | Hiller, J. E., Merlin, T. L., Mundy, L., & Hodgkinson, B. (2002). What is MSAC and what do we do for them?. Poster session presented at the meeting of the Department of Public Health, University of Adelaide. Adelaide, SA. |
| 2002 | Merlin, T. L. (2002). Methodological considerations in a surgical systematic review. Poster session presented at the meeting of Cochrane Non-Randomised Studies Methods Group Meeting. Oxford, United Kingdom. |
| 2001 | Merlin, T. L. (2001). What access method is the safest and most effective at establishing pneumoperitoneum in laparoscopic surgery? A systematic review. Poster session presented at the meeting of the Department of Public Health, University of Adelaide. Adelaide, SA. |
| 2001 | Merlin, T. L. (2001). Tension-free urethropexy: intravaginal slingplasty and the tension-free vaginal tape procedures. Poster session presented at the meeting of the Australasian Scientific Congress, Royal Australasian College of Surgeons. Canberra, ACT. |
| 2000 | Babidge, W., Merlin, T. L., & Maddern, G. (2000). Developing an evidence-based approach for surgery: lessons learned. Poster session presented at the meeting of the Centre for Statistics in Medicine 3rd Symposium on Systematic Reviews: Beyond the Basics – Improving Quality and Impact. Oxford, United Kingdom. |
| 2000 | Merlin, T. L., Walsh, D., & Maddern, G. (2000). Developing clinical practice guidelines for new surgical techniques: beginning with the ABBI. Poster session presented at the meeting of the International Society for Technology Assessment in Health Care (ISTAHC) 16th Annual Meeting. The Hague, the Netherlands. |
| 1990 | Merlin, T. L. (1990). An exploratory study on the viability and efficacy of a Pet-Facilitated Therapy project within a Hospice. Poster session presented at the meeting of the Palliative Care Conference, Daw Park Hospice. Adelaide, SA. |
| Year | Citation |
|---|---|
| 2024 | Laka, M., Carter, D., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2024). International health technology market approval, funding and assessment pathways (1). Canberra: Commonwealth of Australia. |
| 2024 | Tamblyn, D., Morona, J., Carter, D., Kessels, S., & Merlin, T. (2024). Clinical Evaluation Methods in HTA (4). Canberra: Commonwealth of Australia. |
| 2024 | Parsons, J., Milverton, J., Ellery, B., Tamblyn, D., & Merlin, T. (2024). Horizon scanning and early assessment: Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (2). Canberra, ACT: Commonwealth of Australia. |
| 2024 | Newton, S., Hill, H., Tamblyn, D., & Merlin, T. (2024). HTA Methods: Determination of Population, Intervention, Comparator, and Outcome (PICO): Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (3). Canberra, ACT: Commonwealth of Australia. |
| 2024 | Merlin, T., Laka, M., Carter, D., Gao, Y., Choi, Y. -S., Parsons, J., . . . Tamblyn, D. (2024). Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning. Canberra, ACT: Commonwealth of Australia. DOI WoS12 |
| 2020 | Milverton, J., Bellman, S., Schubert, C., Carter, D., Newton, S., Parsons, J., & Merlin, T. (2020). Photodynamic therapy for non-melanoma skin tumours (Document Number MTAR 39/2020/E). |
| 2019 | Kessels, S., Newton, S., Vogan, A., Mittal, R., Schubert, C., Carter, D., . . . Merlin, T. (2019). Clinical utility card for heritable mutations associated with familial hypercholesterolaemia (MSAC Application 1534). Canberra: Commonwealth of Australia. |
| 2019 | Kessels, S., Newton, S., Vogan, A., Mittal, R., Schubert, C., Carter, D., . . . Merlin, T. (2019). Technical report to supplement clinical utility card for heritable mutations associated with familial hypercholesterolaemia (MSAC Application 1534). Canberra: Commonwealth of Australia. |
| 2018 | Milverton, J., Vogan, A., Newton, S., Parsons, J., Schubert, C., & Merlin, T. (2018). Extended half-life clotting factor concentrates for the treatment of haemophilia A and B (MSAC Application 1511). |
| 2018 | Milverton, J., Vogan, A., Parsons, J., Kessels, S., Carter, D., Schubert, C., . . . Merlin, T. (2018). Genetic deletion testing for alpha thalassaemia (MSAC Application 1531). Canberra: Commonwealth of Australia. |
| 2018 | Milverton, J., Mittal, R., Carter, D. A., Kessels, S., Newton, S., Schubert, C., . . . Merlin, T. (2018). Processing and cryopreservation of ovarian tissue prior to or after gonadotoxic treatment to preserve fertility in females for the future (MSAC Application 1435 Part B, Assessment Report). Canberra: Commonwealth of Australia. |
| 2018 | Kessels, S., Mittal, R., Morona, J., Newton, S., Schubert, C., Milverton, J., & Merlin, T. (2018). Anti-Müllerian hormone testing for female patients preceding or following gonadotoxic treatment (MSAC 1434). |
| 2017 | Newton, S. S., Salinger, K., Pridham, L., Parsons, J., & Merlin, T. (2017). Assessment of extended half-life clotting factor concentrates. |
| 2017 | Morona, J., Mittal, R., Newton, S., Salinger, K., Carter, D. A., Schubert, C., & Merlin, T. (2017). Processing and cryopreservation of semen, sperm and testicular tissue prior to or after gonadotoxic treatment to preserve future fertility (MSAC 1435 Part A, Assessment Report). Canberra: Commonwealth of Australia. |
| 2017 | Mittal, R., Kessels, S., Newton, S., Milverton, J., Parsons, J., Morona, J., . . . Merlin, T. (2017). Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene - Resubmission (MSAC application 1216.1). Canberra: Commenwealth of Australia. |
| 2017 | Parsons, J., Merlin, T. L., & Gold, M. (2017). Serious adverse effects associated with human papillomavirus vaccine. World Health Organization. |
| 2017 | Milverton, J., Vogan, A., Newton, S., Schubert, C., & Merlin, T. (2017). 50 gene signature assay for predicting breast cancer recurrence (MSAC Application 1473). |
| 2017 | Parsons, J., Merlin, T. L., & Gold, M. (2017). Serious adverse effects associated with smallpox vaccine. World Health Organization. |
| 2016 | Morona, J., Vogan, A., Kessels, S., Newton, S., Pridham, L., Ellery, B., . . . Merlin, T. (2016). Magnetic resonance imaging of patients with suspected non-ischaemic cardiomyopathies (MSAC 1432). Canberra. |
| 2016 | Tamblyn, D., Schubert, C., & Merlin, T. L. (2016). Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. Commonwealth of Australia. |
| 2016 | Morona, J., Kessels, S., Vogan, A., Mittal, R., Newton, S., Parsons, J., . . . Merlin, T. (2016). Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease (MSAC application number 1237). Canberra, ACT: Commonwealth of Australia. |
| 2016 | Kessels, S., Mittal, R., Morona, J., Newton, S., Ellery, B., Milverton, J., . . . Merlin, T. (2016). Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies (MSAC Application no. 1393). Canberra, ACT: Commonwealth of Australia. |
| 2015 | Newton, S., Ellery, B., Fischer, S., Farah, C., Gum, D., Liufu, Z., . . . Merlin, T. L. (2015). Life Saving Drugs Programme Review: Technical Assessment. Canberra, ACT: Australian Government Department of Health. |
| 2015 | Kessels, S., Morona, J., Mittal, R., Vogan, A., Newton, S., Schubert, C., & Merlin, T. (2015). Testing for hereditary mutations in the Cystic Fibrosis conductance Transmembrane Regulator (CFTR) gene (1216). http://www.msac.gov.au/internet/msac/publishing.nsf/Content/B1083E11E4A3006BCA257BCB0081849E/$File/1216-MSAC-CA-CFTR.pdf: Commonwealth of Australia. |
| 2015 | Ellery, B., Parsons, J., & Merlin, T. L. (2015). Cell salvage as a patient blood management strategy. HealthPACT Commonwealth of Australia. |
| 2014 | Milverton, J., Ellery, B., Gum, D., Newton, S., Kessels, S., Vogan, A., & Merlin, T. (2014). Milverton J, Ellery B, Gum D, Newton S, Kessels S, Vogan A, Merlin T. Computed tomography colonography for the diagnosis or exclusion of colorectal neoplasia. 2014. MSAC Application 1269. Assessment Report. Commonwealth of Australia, Canberra, ACT.. |
| 2014 | Ellery, B., Milverton, J., Newton, S., Morona, J. K., Gum, D., Parsons, J., . . . Merlin, T. (2014). Retinal photography with a non-mydriatic retinal camera in people with diabetes (MSAC Application number 1181). Canberra, ACT.: Commonwealth of Australia. |
| 2014 | Kessels, S., Schubert, C., Parsons, J., Morona, J. K., & Merlin, T. (2014). Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year (MSAC Application number 1162). Canberra, ACT.: Commonwealth of Australia. |
| 2014 | Morona, J. K., Vogan, A., Kessels, S., Gum, D., Milverton, J., Parsons, J., . . . Merlin, T. (2014). Nucleic acid amplification testing for active mycobacterial infection (MSAC Application number 1234). Canberra, ACT.: Commonwealth of Australia. |
| 2014 | Parsons, J., Vogan, A., Morona, J. K., Schubert, C., & Merlin, T. (2014). HBA1c test for the diagnosis of diabetes mellitus (MSAC Application 1267). Canberra, ACT.: Commonwealth of Australia. |
| 2014 | Kessels, S., Schubert, C., Newton, S., & Merlin, T. (2014). Catheter-free (wireless) ambulatory oesophageal pH monitoring for gastro-oesophageal reflux disease (GORD) (1203). Canberra, ACT: Commonwealth of Australia. |
| 2013 | Newton, S., Schubert, C., Morona, J. K., Fitzgerald, P., & Merlin, T. (2013). Genetic testing for hereditary mutations in the RET gene. (MSAC Application 1152). Canberra, ACT.: Commonwealth of Australia. |
| 2012 | Docter, S., Newton, S., Wang, S., Merlin, T. L., Ellery, B., Milverton, J., & Ma, N. (2012). Genetic testing for the diagnosis or prediction of long QT syndrome. Commonwealth of Australia, Canberra, ACT, 2012. ISSN (online) 1443-7139. [on hold at applicant’s request]. |
| 2012 | Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia. |
| 2012 | Smithers, L. G., Lynch, J., & Merlin, T. (2012). Television marketing of unhealthy food and beverages to children: a review of the published evidence since 2009. Canberra: Australian National Preventive Health Agency. |
| 2011 | Merlin, T. L., Street, J., Holton, C., Mundy, L., Tamblyn, D., Juneja, V., . . . Hennessy, S. (2011). Review of MBS items for specific ophthalmology services under the MBS Quality Framework (MSAC Review 1178r). Canberra, ACT: Commonwealth of Australia. |
| 2011 | Farah, C., Schubert, C., & Merlin, T. L. (2011). Detection of K-RAS mutation status to inform treatment with cetuximab (Erbitux). Canberra, ACT. |
| 2011 | Schubert, C., Farah, C., & Merlin, T. L. (2011). Detection of EGFR mutation status to inform treatment with gefitinib (Iressa). Canberra, ACT: Commonwealth of Australia. |
| 2011 | Ellery, B., Mundy, L., Juneja, V., Braunack-Mayer, A., & Merlin, T. L. (2011). Technologies for the inactivation/reduction of pathogens in blood products. Brisbane, QLD: Queensland Health. |
| 2011 | Buckley, E., Docter, S., Morona, J., Reddin, E., Mnatzaganian, G., Juneja, V., & Merlin, T. L. (2011). Prevention, Identification and Management of Foot Complications in Diabetes: Technical Report. Canberra, ACT: Commonwealth of Australia. |
| 2010 | Newton, S., Docter, S., Reddin, E., Merlin, T. L., & Hiller, J. E. (2010). Depression in adolescents and young adults: Evidence Review. Adelaide, SA: BeyondBlue. |
| 2010 | Mundy, L., Braunack-Mayer, A., & Merlin, T. L. (2010). The role of scintimammography in the diagnosis of breast cancer. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2009 | Mundy, L., Liufu., Braunack-Mayer., Merlin, T. L., & Hiller, J. E. (2009). New and emerging technologies for breast cancer detection. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2009 | Buckley, E., & Merlin, T. (2009). Molecular testing for myeloproliferative disease. Part A - Polycythaemia vera, essential thrombocythaemia and primary myelofibrosis. Part B - Systematic mast cell disease, hypereosinophilic syndromes and chronic eosinophilic leukaemia. Canberra, ACT: Commonwealth of Australia. |
| 2009 | Buckley, E., & Merlin, T. (2009). Molecular testing for myeloproliferative disease. Part A - Polycythaemia vera, essential thrombocythaemia and primary myelofibrosis. Part B - Systematic mast cell disease, hypereosinophilic syndromes and chronic eosinophilic leukaemia. Canberra, ACT: Commonwealth of Australia. |
| 2008 | Newton, S., Merlin, T., Hedayati, H., Sullivan, T., Street, J., & Hiller, J. E. (2008). MRI for staging of rectal carcinoma. Canberra, ACT: Commonwealth of Australia. |
| 2008 | Newton, S., Merlin, T., Hedayati, H., Sullivan, T., Street, J., & Hiller, J. E. (2008). MRI for staging of rectal carcinoma. Canberra, ACT: Commonwealth of Australia. |
| 2008 | Buckley, E., Merlin, T. L., & Hiller, J. E. (2008). Vagus nerve stimulation for epilepsy. Canberra, ACT: Commonwealth of Australia. |
| 2008 | Mundy, L., McCaffrey, N., Parsons, J., Liufu, Z., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2008). Quantitative ultrasound. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2008 | Ivan, M., Newton, S., Zimprich, C., Sullivan, T., Merlin, T. L., & Hiller, J. E. (2008). Intragastric balloons for the temporary management of morbid obesity. Canberra, ACT: Commonwealth of Australia. |
| 2008 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2008). Point-of-Care Influenza Diagnostic tests. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2007 | Buckley, L., Merlin, T. L., & Hiller, J. E. (2007). Placement of Acticon artificial bowel sphincters in the management of faecal incontinence. Canberra, ACT: Commonwealth of Australia. |
| 2007 | Merlin, T. L., Hedayati, H., Sullivan, T., Buckley, E. L., Newton, S. S., Hodgkinson, B., . . . Hiller, J. E. (2007). Universal neonatal hearing screening. Canberra, ACT: Commonwealth of Australia. |
| 2007 | Merlin, T. L., Hedayati, H., Wang, S., Sullivan, T., Newton, S., Buckley, E., . . . Hiller, J. E. (2007). Digital mammography for breast cancer screening, surveillance and diagnosis. Canberra, ACT: Commonwealth of Australia. |
| 2007 | Mundy, L., Hiller, J., Braunack-Mayer, A., & Merlin, T. L. (2007). MRI for the detection of foetal abnormalities. Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2007 | Ivan, M., Kreisz, F., Merlin, T. L., Buckley, E., Newton, S., Hedayati, H., . . . Hiller, J. E. (2007). Multi-slice computed tomography coronary angiography in the visualisation of coronary arteries. Canberra, ACT: Commonwealth of Australia. |
| 2007 | Newton, S., Hedayati, H., Sullivan, T., Merlin, T. L., Moss, J., & Hiller, J. E. (2007). Lumbar non-fusion posterior stabilisation devices. Canberra, ACT: Commonwealth of Australia. |
| 2007 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2007). USCOM: ultrasound cardiac output monitor for patients requiring haemodynamic monitoring. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2007 | Buckley, E., Newton, S., Hedayati, H., Merlin, T. L., Moss, J., & Hiller, J. E. (2007). Double balloon enteroscopy. Canberra, ACT: Commonwealth of Australia. |
| 2007 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. (2007). Nanomedicine. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2007 | Merlin, T., Moss, J., Brooks, A., Newton, S., Hedayati, H., & Hiller, J. (2007). Brain natriuretic peptide assays in the diagnosis of heart failure: Part A - in the hospital emergency setting, Part B - in the primary care setting (MSAC application 1087). Canberra: Commonwealth of Australia. |
| 2006 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2006). Molecular adsorbents recirculating system (MARS®): A haemo-dialysis and haemo-filtration device for acute liver failure. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2006 | Mundy, L., Sullivan, T., Merlin, T. L., Braunack-Mayer, A., Elshaug, A., & Hiller, J. (2006). The Pillar procedure: For the treatment of obstructive sleep apnoea and snoring. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2006 | Brooks, A., Merlin, T. L., Mundy, L., Hedayati, H., & Hiller, J. (2006). Uterine artery embolisation. Canberra, ACT: Commonwealth of Australia. |
| 2006 | Merlin, T. L., Newton, S., Hedayati, H., McCaffrey, N., Moss, J., & Hiller, J. (2006). Vertebroplasty and kyphoplasty for the treatment of vertebral compression fracture. Canberra, ACT: Commonwealth of Australia. |
| 2005 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2005). The Meniett™ device for the treatment of Ménière’s disease. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2005 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. (2005). TherOx® AO System: hyperoxemic perfusion for the treatment of microvascular ischaemia in patients with acute myocardial infarction. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2004). The detection of diabetic retinopathy utilising retinal photography in rural and remote areas in Australia. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Mundy, L., Bywood, P., Merlin, T. L., Hodgkinson, B., Fitridge, R., & Hiller, J. E. (2004). Endovenous laser treatment (EVLT™) for varicose veins. Canberra, ACT: Commonwealth of Australia. |
| 2004 | Bywood, P., Newton, S. S., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2004). Computer aided detection systems in mammography. Horizon Scanning Report. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Bywood, P., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2004). Elecsys® ProBNP immunoassay for the diagnosis of congestive heart failure. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2004). MRI screening for breast cancer in genetically high-risk women. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Mundy, L., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2004). GlucoWatch™ for the non-invasive monitoring of glucose levels. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Mundy, L., Hodgkinson, B., Merlin, T. L., Braunack-Mayer, A., & Hiller, J. E. (2004). Left ventricular assist devices for destination therapy. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Mundy, L., Merlin, T. L., Hodgkinson, B., Braunack-Mayer, A., & Hiller, J. E. (2004). Combined CT and PET scanner. Canberra, ACT: Australia and New Zealand Horizon Scanning Network, Commonwealth of Australia. |
| 2004 | Hodgkinson, B., Newton, S., Parsons, J., Hedayati, H., Merlin, T. L., Easterbrook, C., & Hiller, J. E. (2004). Bone densitometry testing. Canberra, ACT: Commonwealth of Australia. |
| 2004 | Hodgkinson, B., Merlin, T. L., Graves, S., Cleland, L., & Hiller, J. E. (2004). Therapeutic arthroscopy for the management of osteoarthritis of the knee: Systematic review. Medical Benefits Fund Australia Limited. |
| 2004 | Bywood, P., Merlin, T. L., Hedayati, H., Parsons, J., & Hiller, J. E. (2004). Tools for service improvement for the prevention, detection and management of chronic diseases. Canberra, ACT: National Health Priority Action Council, Commonwealth of Australia. |
| 2003 | Mundy, L., Merlin, T. L., Maddern, G., & Hiller, J. E. (2003). Placement of artificial bowel sphincters in the management of faecal incontinence. Canberra, ACT: Commonwealth of Australia. |
| 2003 | Hodgkinson, B., Merlin, T. L., Moss, J., Cleland, L., & Hiller, J. E. (2003). Intra-articular viscosupplementation for treatment of osteoarthritis of the knee. Canberra, ACT: Commonwealth of Australia. |
| 2003 | Merlin, T. L., Mundy, L., Moss, J., Dekker, G., & Hiller, J. E. (2003). Antenatal screening for heritable thrombophilia. Canberra, ACT: Commonwealth of Australia. |
| 2002 | Merlin, T. L., Hodgkinson, B., Macintyre, P., Ludbrook, G., & Hiller, J. E. (2002). Institutional approaches to pain assessment and management (008PAI): A systematic literature review. Melbourne, VIC: National Institute of Clinical Studies. |
| 2002 | Parsons, J., Merlin, T. L., Taylor, J., Wilkinson, D., & Hiller, J. E. (2002). Evidence-based practice in a rural and remote setting (013RUR): A critical literature review. Melbourne, VIC: National Institute of Clinical Studies. |
| 2001 | Merlin, T. L., Hiller, J. E., Maddern, G., Jamieson, G., Brown, A., & Kolbe, A. (2001). A systematic review of methods used to establish laparoscopic pneumoperitoneum. Adelaide, SA: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S), Royal Australasian College of Surgeons (RACS), Commonwealth of Australia. |
| 2001 | Merlin, T. L., Arnold, E., Petros, P., MacTaggart, P., Tulloch, A., Jamieson, G., . . . Maddern, G. (2001). A systematic review of tension-free urethropexy for stress urinary incontinence: intravaginal slingplasty and the tension-free vaginal tape procedures. Adelaide, SA: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S), Royal Australasian College of Surgeons (RACS), Commonwealth of Australia. |
| 2000 | Merlin, T. L., Scott, D., Rao, M., Wall, D., Francis, D., Bridgewater, F., & Maddern, G. (2000). Systematic review of laparoscopic live donor nephrectomy. Updated and re-appraised 2000. Adelaide, SA: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S), Royal Australasian College of Surgeons (RACS), Commonwealth of Australia. |
| 2000 | Walsh, D., Merlin, T. L., Humenuik, V., Malycha, P., Cregan, P., Lord, A., & Maddern, G. (2000). Clinical practice guidelines for the advanced breast biopsy instrument (ABBI). Adelaide, SA: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S), Royal Australasian College of Surgeons (RACS), Commonwealth of Australia. |
| 1999 | Merlin, T. L., Scott, D., Rao, M., Wall, D., Francis, D., Bridgewater, F., & Maddern, G. (1999). Systematic review of laparoscopic live donor nephrectomy. Adelaide, SA: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S), Royal Australasian College of Surgeons (RACS), Commonwealth of Australia. |
| Year | Citation |
|---|---|
| 2020 | Authors: Newton S, Morona J, Salinger K, Merlin T. Title: Evidence evaluation report: Systematic literature review on the association between alcohol consumption and mental health disorders. Description: N/A. Extent: N/A. |
| 2016 | Authors: Merlin T. Title: Clinical Practice Guidelines and Principles of Care for People with Dementia. Description: N/A. Extent: N/A. |
| 2016 | Authors: Merlin T. Title: Patient Blood Management Guidelines: Module 6 - Neonatal and Paediatrics. Description: N/A. Extent: N/A. |
| 2015 | Authors: Morona J, Tamblyn D, Ellery B, Merlin T. Title: National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Description: N/A. Extent: N/A. |
| 2015 | Authors: National Health and Medical Research Council. Title: NHMRC Statement: Evidence on Wind Farms and Human Health. Description: N/A. Extent: N/A. |
| 2015 | Authors: Merlin T. Title: Patient Blood Management Guidelines: Module 5 Obstetrics and Maternity. Description: N/A. Extent: N/A. |
| 2013 | Authors: Phoenix Australia - Centre for Postraumatic Mental Health. Title: Australian guidelines for the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder. Description: N/A. Extent: N/A. |
| 2012 | Authors: Newton S, Parsons J, Ellery B, Milverton J, Morona J, Docter S, Liufu Z, Merlin TL. Title: Update of the Australian guidelines for the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder. Description: N/A. Extent: N/A. |
| 2012 | Authors: Merlin TL. Title: Patient Blood Management Guidelines: Module 4 – Critical Care. Description: N/A. Extent: N/A. |
| 2012 | Authors: Merlin TL. Title: Patient Blood Management Guidelines: Module 3 – Medical. Description: N/A. Extent: N/A. |
| 2012 | Authors: Merlin TL, Newton S. Title: Patient Blood Management Guidelines: Module 2 – Perioperative. Description: N/A. Extent: N/A. |
| 2011 | Authors: Merlin T, Newton S. Title: Patient blood management guidelines, Module 1 - Critical bleeding/massive transfusion. Description: N/A. Extent: N/A. |
| 2011 | Authors: Fitridge R, Templeton S, Buckley E, Docter S, Morona J, Reddin E, Juneja V, Merlin T. Title: National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes. Description: N/A. Extent: N/A. |
| 2011 | Authors: Merlin T, Newton S. Title: Clinical practice guidelines: Depression in adolescents and young adults. Description: N/A. Extent: N/A. |
| 2008 | Authors: Cox M, Frank O, Osti O, Merlin T, Atkinson R, Jezukaitis P. Title: Clinical guidelines for best practice management of acute and chronic whiplash-associated disorders. Description: N/A. Extent: N/A. |
| 2008 | Authors: Hiller J, Merlin T. Title: Guidelines for the management of diabetic retinopathy. Description: N/A. Extent: N/A. |
| 2007 | Authors: McFarlane A, Newton S, Hedayati H, McCaffrey N, Erkelens M, Hazel S, Steggles E, Hiller J. Title: Guidelines for the Treatment of Adults with Acute Stress Disorder and Posttraumatic Stress Disorder. Description: N/A. Extent: N/A. |
| Year | Citation |
|---|---|
| 2021 | Lopes McInnes, E. (2021). The Rationale and Design of Public Involvement in Health Technology Assessment: A Systems Thinking Approach. (PhD Thesis, The University of Adelaide). |
| 2021 | Laka, M. (2021). The Role of Computer Computer-based Clinical Decision Support Systems (CDSS) in Improving Antibiotic Management. (PhD Thesis, The University of Adelaide). |
| 2015 | Moshi, M. R. (2015). Delivering a universal neonatal screening programme for sickle cell anaemia in sub- Saharan Africa. |
| 2014 | Lopes McInnes, E. (2014). Public and patient involvement in government health funding decision making in Australia. (Master's Thesis, The University of Adelaide). |
| Year | Citation |
|---|---|
| 2017 | Carter, D. A., & Merlin, T. (2017). Sharing risk in the funding of health technologies. School of Public Health. |
Research Funding
National Competitive Schemes
| Date | Project/No. | Investigators | Funding Body | Amount | |
|---|---|---|---|---|---|
| 2022-2027 |
|
CIA: Karin Kassahn, CIB: Enzo Ranieri….CIL: Tracy Merlin…. AI: Camille Schubert… |
Medical Research Future Fund – Genomics Health Futures Mission | $2,941,351 | |
| 2020-2023 |
Genomic Autopsy Study for Stillbirth - Lead, substudy on changes in clinical management and cost-effectiveness of genomic testing. Grant ID -GHFM76777 |
Prof Hamish Scott, A/Prof Christopher Barnett, Prof Tracy Merlin + others | Medical Research Future Fund – Genomics Health Futures Mission | $3,401,790 | |
| 2018 | ReMInDAR Trial - Reducing Medicine Induced Deterioration and Adverse Reactions | Prof Libby Roughead - UniSA Prof Tracy Merlin – Adelaide University AHTA Prof Tim Olds / A/Prof Gaynor Parfitt – UniSA ARENA A/Prof Luke Bereznicki – University of Tasmania A/Prof Nicole Pratt – UniSA Ms Jo Boylan / Ms Ai Choo Kang– Southern Cross Care SA NT Ms Megan Corlis – Helping Hand Aged Care Inc Mr Adam Phillips – Terry White Chemmart Dr Renly Lim - UniSA |
Pharmacy Trial Program - Tranche 2 | $2,847,926 | |
| 2012-2013 | Steward or nanny state: Consulting the public about the use of regulations and laws to address childhood obesity | Chief - Braunack-Mayer AJ, Street, JM, Reynolds C, Moore V, Warin M, Carter D, Moss J, Merlin T. | Australian National Preventive Health Agency Research Grants Program 2011-12 | $288,381 | |
| 2009-2011 | Changing policy and practice in health care |
Chief - Hiller J, Elshaug A, Braunack-Mayer A, Moss J, Wale J, Buchan H. Associate – Littlejohns P, Wells R, Phillips P, Goss A, Norman R, Southcott A, Karnon J, Merlin T, de Lacey S, Street J. |
NHMRC Project Grant | $860,750 | |
| 2009-2013 | Health care in the round: building capacity for integrated decision-making for improving health services. | Chief - Jamrozik K, Hiller J, Braunack-Mayer A, Gericke C, Ryan P, Karnon J, Nasir R, Beilby J. Mentors - Moss J, Van der Wilt G, Sculpher M, Rogers W, Merlin T, Furler L. | NHMRC Capacity Building Grants in Population Health and Health Services Research | $2,352,714 |
Contract Research - Public Sector Funding
| Date | Project/No. | Investigators | Funding Body | Amount | |
|---|---|---|---|---|---|
| April 2023 – April 2024 |
The HTA Policy and Methods Review of Australia Services to review existing Health Technology Assessment processes as per Strategic Agreement between the Commonwealth and Medicines Australia |
Merlin T, Tamblyn D, Newton S, Parsons J, Ellery B, Carter D | Department of Health and Aged Care (Technology Access and Assessment Division; and Therapeutic Goods Administration), Australian Government |
|
|
|
Services for Health Technology Assessment, Research Support and Other Services | Merlin T, Newton S, Parsons J, Tamblyn D, Vogan A, Schubert C, Liufu V, Ellery B, Carter D, Scott H, Kassahn K. | Department of Health and Aged Care (Technology Access and Assessment Division; and Therapeutic Goods Administration), Australian Government | $3,500,000 + | |
| 2021-2025 | External evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee | Merlin T, Wang S, Tamblyn D, Schubert C. | Department of Health (Pharmaceutical Benefits Branch), Australian Government |
Minimum: $5,821,975 (Maximum: up to $8,654,635) |
|
| 2019-2020 | Review of the MSAC Technical Guidelines (therapeutic & investigative) and administrative documents | Merlin T, Newton S, Tamblyn D, Vogan A, Kessels S, Morona J, Wyndham A, Sinclair A, Kip M. | Department of Health (Technology Access and Assessment Division), Australian Government | $792,794 | |
| 2019-2025 | Services for Health Technology Assessment, Research Support and Other Services | Merlin T, Newton S, Parsons J, Tamblyn D, Schubert C, Wang S, Carter D, Marshall H, Gold M. | Department of Health (Technology Access and Assessment Division; and Therapeutic Goods Administration), Australian Government | Up to $12 million over 6 years | |
| 2018 | Review of the processes and procedures to support the Australian Technical Advisory Group on Immunisation (ATAGI) | Merlin T, Parsons J, Schubert C | Department of Health, Australian Government | $56,019 | |
| 2018-2021 |
Provision of Medical and Scientific Evaluation Services
|
Merlin T, Tamblyn D, Farah C, Tonkin A, Reddi B, Gum D, Liufu Z, Morona J, Wyndham A. | Therapeutic Goods Administration | $110,062 | |
| 2018 |
NHMRC Health Evidence, Advice and Methods Panel Systematic Review on alcohol and mental health |
Merlin T, Newton S, Morona J | National Health and Medical Research Council | $111,381 | |
| 2017-2018 | Develop an HTA review pathway and methodology | Merlin T, Schubert C. |
Department of Health, Australian Government Technology Access and Assessment Division |
$56,324 | |
| 2017-2018 | Systematic literature review and review of clinical guidelines concerning medicines used to treat pulmonary arterial hypertension (PAH) | Merlin T, Liufu Z, Wyndham A, Morona J. | Department of Health, Australian Government | $218,981 | |
| 2017 | Review of Breast Implants | Merlin T, Tamblyn D, Parsons J. | Therapeutic Goods Administration | $237,918 | |
| 2017 | Clinical evaluation of medical device applications | Merlin T, Tamblyn D, Salinger K. | Therapeutic Goods Administration | $300,000 | |
| 2016-2018 | Veterans’ Medicine Advice and Therapeutics Education Services Program (Veterans’ MATES) |
Roughead E, Le Blanc V, Barratt J, Pratt N, Kalisch-Ellett L, Ramsay E, Milburn A. Subcontractor: AHTA |
Department of Veterans’ Affairs, Australian Government | $246,660 | |
| 2016-2020 | External evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee | Merlin T, Wang S, Schubert C, Tamblyn D. | Department of Health (Pharmaceutical Benefits Branch), Australian Government | $3,851,303 (minimum) | |
| 2015-2016 | Review of Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee | AHTA - Merlin T, Tamblyn D, Schubert C ; Consultants - Karnon J, Afzali H, Sculpher M, Drummond M, Roughead L, Sullivan T.; Editors - Biotext (Editorial) – Salisbury J, Irish, J. | Department of Health (Pharmaceutical Benefits Branch) | $539,842 | |
| 2015-2018 | Provision of Health Technology Assessment Services to the Medical Services Advisory Committee (MSAC HTA Panel) | AHTA - Merlin T, Newton S, Schubert C, Parsons J, Street J, Carter D, Sullivan T. ; JBI – Aromataris E et al. | Department of Health (Medicare Benefits Branch) | ~approx $3 million over 3 years | |
| 2015-2016 | Professional services in relation to the development of emerging technology briefs on behalf of the Health Policy Advisory Committee on Technology (HealthPACT) | Merlin T, Parsons J, Ellery B. | Queensland Health | $147,263 | |
| 2014-2015 | Review of Life Saving Drugs Program | Merlin T. | Postmarket Reviews of PBS Medicines, Pharmaceutical Benefits Branch, Department of Health and Ageing | $326,505 | |
| 2014 | Professional services in relation to the development of emerging technology briefs on behalf of the Health Policy Advisory Committee on Technology (HealthPACT) | Merlin T, Parsons J, Ellery B. | Queensland Health | $43,312 | |
| 2013-2015 | Provision of Health Technology Assessment Services to the Medical Services Advisory Committee (MSAC HTA Panel) | Merlin T, Newton S, Schubert C, Parsons J, Street J. | Department of Health and Ageing (Medicare Benefits Branch) | $2,057,250 | |
| 2012-2013 | Systematic literature review of wind farms and human health | Merlin T. | National Health and Medical Research Council | $92,134 | |
| 2012-2016 | External evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee | Merlin T, Moss J, Wang S, Schubert C. | Department of Health and Ageing (Pharmaceutical Benefits Branch) | $5,455,151 | |
| 2012 | Systematic review of exposure of children to ‘unhealthy’ food and beverage advertising on television. | Merlin T, Smithers L, Lynch J. | Australian National Preventive Health Agency | $51,194 | |
| 2012 | Review of Skin Service items on the MBS | Merlin T, Street J, Parsons J. | Department of Health and Ageing (Medicare Benefits Division) | $85,000 | |
| 2010-2012 | Systematic reviews of Ophthalmology specialty items on the MBS | Merlin T, Street J, Holton C. | Department of Health and Ageing (Medicare Benefits Division) | $291,369 | |
| 2008-2012 | External evaluation of vaccine and pharmaceutical submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for funding under the Pharmaceutical Benefits Scheme | Merlin T, Moss J, Hiller J. | Department of Health and Ageing (Pharmaceutical Benefits Branch) | $4,045,753 | |
| 2008-2012 | Provision of health technology assessment and research related support services, including independent evaluation of services under consideration by the Medical Services Advisory Committee (MSAC) for Medicare funding. | Merlin T, Hiller J, Braunack-Mayer A, Elshaug A, Karnon J, Moss J, Street J. | Department of Health and Ageing (Medical Benefits Division) | $2,500,000 | |
| 2011 | Technologies for the inactivation/ reduction of pathogens in blood products. | Merlin T. | Queensland Health | $30,366 | |
| 2009-2011 | Systematic review and update of Type 2 Diabetes Clinical Practice Guidelines | Mott K, Merlin T, Shaw J, Neil B, Zimmet P, Zoungas S. | Department of Health and Ageing (Chronic Disease Division) | $1,366,582 | |
| 2010 | Development of a framework and methodology for evaluating co-dependent technologies (personalised medicines). | Merlin T. | Department of Health and Ageing (Medicare Benefits Division and Pharmaceutical Benefits Division) | $51,486 | |
| 2009 | Systematic review and development of clinical practice guidelines on the management of acute/subacute soft tissue injury to the lower back | Merlin T, Hiller J. | WorkCover SA | $115,000 | |
| 2009 | Development and provision of horizon scanning services for prevention of injury, rehabilitation and compensation | Hiller J, Merlin T, Mundy L. | New Zealand Accident Compensation Corporation | $55,677 | |
| 2007-2009 | External evaluation of vaccine submissions to the Pharmaceutical Benefits Advisory Committee | Merlin T, Hiller J. | Department of Health and Ageing (Pharmaceutical Benefits Branch) | $394,027 | |
| 2008 | Systematic review and development of clinical practice guidelines on the management of acute/subacute soft tissue injury to the lower back | Hiller J, Merlin T. | South Australian Centre for Trauma and Injury Recovery (TRACsa) | $77,069 | |
| 2006-2010 | Provision of Horizon Scanning services on behalf of the Health Policy Advisory Committee on Technology | Hiller J, Merlin T, Mundy L, Braunack-Mayer A. | Department of Health and Ageing (Medicare Benefits Division) | $1,166,461 | |
| 2005-2009 | Provision of Assessment and Research Related services on Medical Technologies and Procedures for the Medical Services Advisory Committee | Hiller J, Merlin T, Moss J, Braunack-Mayer A, Ryan P. | Department of Health and Ageing (Medicare Benefits Division) | $1,594,372 | |
| 2004-2008 | External evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee. | Moss J, Hiller J, Merlin T, Tonkin A. | Department of Health and Ageing (Pharmaceutical Benefits Branch) | $2,618,082 | |
| 2005-2008 | Provision of Horizon Scanning services on behalf of the Medical Services Advisory Committee and the Australian Health Ministers Advisory Council | Hiller J, Merlin T. | Department of Health and Ageing (Medicare Benefits Division) | $237,304 | |
| 2003-2005 | Establish National Horizon Scanning Unit | Hiller J, Merlin T. | Department of Health and Ageing (Medicare Benefits Division) | $460,560 | |
| 2004 | NHMRC clinical practice guidelines and national tolerisation protocols for the use of recombinant and plasma derived Factor VIII and Factor IX products for the treatment and management of haemophilia | Hiller J, Merlin T. | National Blood Authority | $77,450 | |
| 2003-2004 | Systematic literature review on effective tools for service improvement in the national health priority action areas | Hiller J, Merlin T, Bywood P, Cleland L, Ruffin R, Olver I, Tonkin A, Wittert G, Hay. | National Health Priority Action Council, Department of Health and Ageing | $49,500 | |
| 2002-2004 | Systematic literature review on approaches to pain assessment and management | Hiller J, Merlin T, Ludbrook G, McIntyre P. | National Institute of Clinical Studies | $60,500 |
Contract Research and Grants - Australian Industry, donations and international grants
| Date | Project/No. | Investigators | Funding Body | Amount |
|---|---|---|---|---|
| 2024-2026 | Development and implementation of the Australian Motor Neurone Disease (MND) Guidelines | Munn Z, Barker T, Pollock D, McBride G, Hasanoff S, Castellano J, Schubert C, Giles L, Merlin T. | FightMND | $2,000,000 |
| 2020 - 2025 | Health technology assessment services for the Agency for Care Effectiveness | Merlin, T, Newton S, Liufu V, Parsons J, Vogan A, Milverton J | Singapore Ministry of Health | $450,000+ |
| 2020 | Adverse events associated with cholera and yellow fever vaccines | Merlin T, Gold M, Parsons J | World Health Organisation | $84,474 |
| 2017-2018 | Multidisciplinary study into the impact of communication assistance for witnesses with complex communication needs under the Statutes Amendment (Vulnerable Witnesses) Act | Caruso D, Tooher R, Merlin T, Plater D, Langos C, Le Couteur A, Wade N | Law Foundation of SA | $93,634 |
| 2016-2017 | Adverse events associated with HPV vaccines and Smallpox vaccines | Merlin T, Gold M, Parsons J. | World Health Organization | $40,086 |
| 2016-2017 | Systematic review of scientific literature concerning blood products treating haemophilia | Merlin T, Newton S. | Australian Haemophilia Centre Directors’ Organisation | $87,095 |
| 2016-2017 | Health technology assessment for submission to the Medical Services Advisory Committee | Merlin T. | NanoString Diagnostics Pty Ltd | $149,374 |
| 2011-2012 | Development of NHMRC clinical practice guidelines on the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder in adults and children. Update. | Merlin T. | Australian Centre for Posttraumatic Mental Health | $179,852 |
| 2008-2009 | Systematic review and update of NHMRC clinical practice guidelines for depression in young people | Merlin T, Hiller J. | Beyondblue: the national depression initiative | $179,445 |
| 2005-2006 | Development of NHMRC clinical practice guidelines on the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder | Merlin T, Hiller J. | Australian Centre for Posttraumatic Mental Health | $49,167 |
| 2004 | Systematic literature review on therapeutic arthroscopy for the management of osteoarthritis of the knee. | Hiller J, Merlin T , Ryan P, Graves S, Cleland L. | Medical Benefits Fund (MBF Australia) | $57,000 |
Internal support for trials and studies
| Date | Project description | Services provided | Institution | Amount |
|---|---|---|---|---|
| 2017-2020 |
Randomised controlled trial comparing STan intrapartum fetal monitoring with CTG monitoring alone (START trial) Deborah Turnbull and Chris Wilkinson, CIs |
|
University of Adelaide Funded: NHMRC Project Grant |
$176,940 |
| 2017-2019 |
Meningococcal B vaccination randomised controlled trial (“B Part of It”) Helen Marshall, CI |
|
University of Adelaide Funded: SA Health and Glaxosmithkline |
$525,500 |
Teaching Activities
Prof Merlin has successfully supervised numerous research students at Honours, Masters and PhD level.
Prof. Merlin teaches undergraduate level topics including Systematic Review, Meta-analysis, Policy Evaluation, Clinical Epidemiology and Health Technology Assessment to Bachelor of Health Sciences, Bachelor of Health Service Management and Doctor of Medicine students. She also teaches a postgraduate online course in Health Technology Assessment for Master of Public Health student and for auditing HTA professionals.
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Principal Supervisor | What factors should Health Technology Assessment committees consider when deliberating funding recommendations for interventions given at the end-of-life? | Doctor of Philosophy | Doctorate | Full Time | Ms Rebecca Trowman |
| 2025 | Principal Supervisor | What factors should Health Technology Assessment committees consider when deliberating funding recommendations for interventions given at the end-of-life? | Doctor of Philosophy | Doctorate | Full Time | Ms Rebecca Trowman |
| 2024 | Co-Supervisor | Establishing an evidence-based framework for developing diagnostic criteria for conditions with no obvious test, biomarker or reference standard | Doctor of Philosophy | Doctorate | Full Time | Dr Sam White |
| 2024 | Principal Supervisor | The Application of Artificial Intelligence (AI) in HTA: Exploring the Risks and Benefits. | Doctor of Philosophy | Doctorate | Full Time | Miss Yuan Gao |
| 2024 | Principal Supervisor | The Application of Artificial Intelligence (AI) in HTA: Exploring the Risks and Benefits. | Doctor of Philosophy | Doctorate | Full Time | Miss Yuan Gao |
| 2024 | Co-Supervisor | Establishing an evidence-based framework for developing diagnostic criteria for conditions with no obvious test, biomarker or reference standard | Doctor of Philosophy | Doctorate | Full Time | Dr Sam White |
| 2023 | Principal Supervisor | Developing a Health Technology Assessment framework for the evaluation and reimbursement of multi-use pharmaceuticals | Doctor of Philosophy | Doctorate | Part Time | Mr Isaiah Luc |
| 2023 | Principal Supervisor | Developing a Health Technology Assessment framework for the evaluation and reimbursement of multi-use pharmaceuticals | Doctor of Philosophy | Doctorate | Full Time | Mr Isaiah Luc |
| 2021 | Principal Supervisor | Assessing the clinical utility and cost-effectiveness of genomic testing in perinatal autopsy to determine the cause of miscarriage or stillbirth: a change in management study and cost-effectiveness analysis. | Doctor of Philosophy | Doctorate | Full Time | Ms Camille Schubert |
| 2021 | Principal Supervisor | Assessing the clinical utility and cost-effectiveness of genomic testing in perinatal autopsy to determine the cause of miscarriage or stillbirth: a change in management study and cost-effectiveness analysis. | Doctor of Philosophy | Doctorate | Full Time | Ms Camille Schubert |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2019 - 2022 | Principal Supervisor | The Role of Computer Based Clinical Decision Support Systems (CDSS) in Improving Antibiotic Management | Doctor of Philosophy | Doctorate | Full Time | Ms Mahlaka HASSAN |
| 2017 - 2022 | Principal Supervisor | Investigating an alternative regulatory and reimbursement framework for antimicrobials in Australia | Doctor of Philosophy | Doctorate | Part Time | Dr Nadine Therese Hillock |
| 2016 - 2020 | Principal Supervisor | Feasibility of a Reimbursement Pathway for Mobile Medical Applications (MMA) in Australia | Doctor of Philosophy | Doctorate | Full Time | Magdalena Ruth Moshi |
| 2016 - 2021 | Co-Supervisor | The Rationale and Design of Public Involvement in Health Technology Assessment: A Systems Thinking Approach | Doctor of Philosophy | Doctorate | Full Time | Dr Edilene Lopes McInnes |
| 2013 - 2014 | Co-Supervisor | PUBLIC AND PATIENT INVOLVEMENT IN GOVERNMENT HEALTH FUNDING DECISION MAKING IN AUSTRALIA | Master of Philosophy (Public Health) | Master | Part Time | Dr Edilene Lopes McInnes |
| 2012 - 2016 | Co-Supervisor | The impact of findings from grey literature on the outcomes of systematic reviews on interventions to prevent obesity among children | Master of Clinical Science | Master | Full Time | Ms Jessica Dorothy Tyndall |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2023 - 2026 | Member | HTAi Global Policy Forum | Canada |
| 2020 - ongoing | Member | Public Health Association of Australia | Australia |
| 2017 - 2018 | Member | International Real World Evidence Task Group, INAHTA Representative | - |
| 2016 - ongoing | Member | International Society of Pharmacoeconomics Outcomes Research (ISPOR) | Australia |
| 2013 - 2023 | Member | Guidelines International Network (G-I-N) | United Kingdom |
| 2013 - ongoing | Member | Society of Medical Decision Making | - |
| 2010 - 2019 | Member | Health Services Research Association of Australia and New Zealand | Australia |
| 2006 - ongoing | Member | International Network of Agencies for Health Technology Assessment (INAHTA) | - |
| 2003 - ongoing | Member | Health Technology Assessment International (HTAi) | - |
| 2003 - 2020 | Member | Cochrane Systematic Reviews of Diagnostic Tests Methods Group | United Kingdom |
| 2002 - 2020 | Member | Cochrane Non-Randomised Studies Methods Group | United Kingdom |
| 1991 - 2003 | Member | Public Health Association of Australia | Australia |
| 1991 - 1993 | Member | Public Health Association of Australia | Australia |
| Date | Institution | Department | Organisation Type | Country |
|---|---|---|---|---|
| 2018 - 2023 | National Health and Medical Research Council | National Health and Medical Research Council | Health services and related | Australia |
| 2014 - 2014 | National Health and Medical Research Council | Cognitive Decline Partnership Centre, National Dementia Guidelines, Methodological consultant to determine consistency with NHMRC standards and approaches for evidence-based Guideline development. | Health services and related | Australia |
| 2013 - 2016 | National Health and Medical Research Council | Health Advice Panel member, services relevant to the development and presentation of evidence based health advice. | Health services and related | Australia |
| 2013 - 2014 | Australian Government | National Drugs and Poisons Scheduling Committee, Office of Health Protection, Department of Health and Ageing, Review of drug submissions to move from one Poisons Schedule to another. | Health services and related | Australia |
| 2013 - 2013 | Australian Centre for Posttraumatic Mental Health | Posttraumatic Mental Health, Consultant on methods for conducting rapid reviews. | Health services and related | Australia |
| 2011 - 2021 | SA Health Pharmaceutical Services and Strategy Branch | Independent review of South Australian Medicines Evaluation Panel (SAMEP) process for evaluation of high cost medicines. Panel was awarded “Excellence in Non-Clinical services” by SA Health in 2014. | Health services and related | Australia |
| 2010 - 2015 | Australian Government | National Blood Authority, Methodological consultant to determine consistency with NHMRC standards and approaches for evidence-based Guideline development. | Health services and related | Australia |
| 2010 - 2013 | National Health and Medical Research Council | Expert Panel Member, Providers with expertise relevant to the development and presentation of evidence based health advice. | Health services and related | Australia |
| 2009 - 2012 | Australian Government | National Drugs and Poisons Scheduling Committee, Office of Health Protection, Department of Health and Ageing, Review of drug submissions to move from one Poisons Schedule to another. | Health services and related | Australia |
| 2008 - 2010 | NHMRC | National Blood Authority and the Australian and New Zealand Blood Transfusion Society, Review and development of “Clinical Practice Guidelines on the Use of Blood Components” in collaboration with the National Blood Authority and the Australian and New Zealand Blood Transfusion Society. | Health services and related | Australia |
| 2006 - 2010 | Australian Government | Department of Health and Ageing, Member, Register of Prospective Independent Reviewers. Conduct independent reviews of Pharmaceutical Benefits Advisory Committee (PBAC) recommendations not to list a drug or medicinal preparation on the Pharmaceutical Benefit Scheme (PBS). | Health services and related | Australia |
| 2006 - 2010 | National Health and Medical Research Council | NHMRC Guideline Assessment Register, Preferred provider for the provision of evidence-based medicine expertise to organisations developing clinical practice guidelines for National Health and Medical Research Council (NHMRC) approval. | Health services and related | Australia |
| 2006 - 2009 | Australian Government | Department of Health and Ageing, Panel of Providers of Health Economics Services. | Health services and related | Australia |
| 2006 - 2008 | NHMRC | Department of Health and Ageing, Review and development of “NHMRC Best Practice Management (including assessment and treatment) of acute and chronic whiplash associated disorders” in collaboration with South Australian Centre for Trauma and Injury Recovery (TRACsa). | Health services and related | Australia |
| 2005 - 2005 | National Health and Medical Research Council | National Stroke Foundation, Consultancy to NHMRC to critically appraise evidence base in “Clinical Guidelines for Stroke Rehabilitation and Recovery”. | Health services and related | Australia |
| 2004 - 2006 | Department of Human Services | Clinical Innovation Agency, Victoria, Preferred provider of systematic literature reviews. | Health services and related | Australia |
| 2003 - 2004 | National Health and Medical Research Council | Review and development of “NHMRC Clinical Practice Guidelines on the Management of Diabetic Retinopathy” in collaboration with Australian Diabetes Society | Health services and related | Australia |
| 2002 - 2005 | National Health and Medical Research Council | NHMRC Guideline Assessment Register, Preferred provider for the provision of evidence-based medicine expertise to organisations developing clinical practice guidelines for National Health and Medical Research Council (NHMRC) approval. | Health services and related | Australia |
| 2001 - 2002 | National Health and Medical Research Council | Review of draft Clinical Practice Guidelines for Management of Early Prostate Cancer. | Health services and related | Australia |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2014 - 2023 | Editor-In-chief | English Editorial Board of the International Health Technology Assessment (HTA) Glossary | International HTA Glossary | Australia |
| 2013 - ongoing | Member | GMS Health Technology Assessment | German Medical Science | Germany |
| Date | Topic | Presented at | Institution | Country |
|---|---|---|---|---|
| 2023 - 2023 | ICER thresholds in reimbursement frameworks: challenges and experiences in the Asia Pacific | HTAi 2023 Annual Meeting | Health Technology Assessment international | Australia |
| 2023 - 2023 | Can regulators and health technology assessment agencies sing from the same hymn sheet? Exploring the benefits and challenges. d experiences in the Asia Pacific | HTAi 2023 Annual Meeting | Health Technology Assessment international | Australia |
| 2023 - 2023 | A Workshop to Learn About “Why” And “How” To Assess The Impacts Of Health Technology Assessment. | HTAi 2023 Annual Meeting | Health Technology Assessment international | Australia |
| 2023 - 2023 | HTA impact assessment | HTAi Global Policy Forum | Health Technology Assessment international | Netherlands |
| 2021 - 2021 | HTA Methods in Challenging Times | HTAi Asia Policy Forum | Health Technology Assessment international | Singapore |
| 2021 - 2021 | The current regulatory and HTA landscape in maturing markets for the assessment of medicines: How is it changing and what are the considerations? | - | Centre for Innovation and Regulatory Science | United Kingdom |
| 2021 - 2021 | HTA in the post-pandemic era: INAHTA Perspective | - | HTAsiaLink | Indonesia |
| 2021 - 2021 | Applications of Health Technology Assessment | Asian Conference on Clinical Pharmacy | Asian Conference on Clinical Pharmacy | Singapore |
| 2021 - ongoing | Evidence for HTA: Innovative Methods for Challenging Times | HTAi 2021 Annual Meeting | Health Technology Assessment international | United Kingdom |
| 2021 - 2021 | Evidence for HTA: Innovative Methods for Challenging Times | HTAi 2021 Annual Meeting, Manchester | Health Technology Assessment international | United Kingdom |
| 2021 - 2021 | HTA Global collaboration – International collaborations on policy and technical issues. What outcome would be of value and most benefit to patients? s for the assessment of medicines: How is it changing and what are the considerations? | - | Centre for Innovation and Regulatory Science | United Kingdom |
| 2021 - 2021 | HTA Global collaboration – International collaborations on policy and technical issues. What outcome would be of value and most benefit to patients? | - | Centre for Innovation in Regulatory Science | United Kingdom |
| 2021 - 2021 | HTA and the Art of Decision Making | Online. | Agency for Care Effectiveness, Singapore Ministry of Health | Singapore |
| 2021 - ongoing | COVID-19: How did we develop the first roadmap to recovery? | - | University of Adelaide | Australia |
| 2021 - 2021 | Tumour agnostic therapies | INAHTA Congress | International Network of Agencies for Health Technology Assessment | United Kingdom |
| 2020 - 2020 | Health for all – Research that shapes public access to medicines, tests, devices and procedures | - | SAHMRI | Australia |
| 2017 - 2017 | Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Evaluator Workshop | Canberra | AHTA, presenting at request of Australian Government Department of Health | Australia |
| 2016 - 2016 | Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review Submission Sponsor Workshop | Sydney (3), Melbourne (2) | AHTA, presenting at request of Australian Government Department of Health | Australia |
| 2014 - 2014 | Evaluating medical tests for coverage decisions using the linked evidence approach | HTAi 11th Annual Meeting, Washington | AHTA, University of Adelaide | United States |
| 2013 - 2013 | HTA Workshop for Government staff | Woden, Canberra | AHTA for the Australian Commonwealth Government Department of Health and Ageing | Australia |
| 2012 - 2012 | Evaluating Co-dependent submissions to inform PBAC decision making | Woden, Canberra | AHTA for the Australian Commonwealth Government Department of Health | Australia |
| 2011 - 2011 | A Brief Introduction to Health Technology Assessment (HTA) | Woden, Canberra | AHTA for the Australian Commonwealth Government Department of Health and Ageing | Australia |
